Breathalyzer for COVID-19 detection in military settings

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to optimize and operationalize the A&M Breathalyzer PROTECT Kiosk for the passive detection of COVID-19 in military environments. Conducted at Brooke Army Medical Center, the study will evaluate the effectiveness of this innovative diagnostic tool in identifying both asymptomatic and symptomatic individuals. The research involves collaboration between military medical professionals and biotechnology experts to assess the kiosk's capabilities and adapt it for various operational scenarios. The goal is to enhance rapid and reliable COVID-19 diagnostics to improve military readiness and reduce the impact of respiratory infections.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Asymptomatic and symptomatic individuals 18 years and older
* Receiving standard COVID-19, Flu and/or RSV screening and testing at BAMC
* Do not have to be diagnosed with SARS-CoV-19 (COVID-19) but only be screened
* Ability to understand consent

Exclusion Criteria:

* Any individual under age of 18
* Anyone unable to comply (or be assisted) with study procedures
* Anyone not able to provide temperature thermal scan, and/or perform exhaled breath for approximately 8 seconds

Where it's running

• Brooke Army Medical Center
  Fort Sam Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Tony Yuan, PhD — Uniformed Services University of the Health Sciences (USUHS)
• Study coordinator: Tony Yuan, PhD
• Email: tony.yuan@usuhs.edu
• Phone: 214-292-0508

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding heart function in COVID-19 survivors using MRI

  This study is trying to see how heart scans can help understand heart function and long-term symptoms in people who have survived COVID-19.

  Recruiting at 3 sites Weill Medical College of Cornell University · Brooklyn, New York and 2 other locations · NCT05164744

• Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) in Adults

  This study tests and compares the immune responses and tolerability of the latest COVID-19 vaccines from Novavax and Pfizer/BioNTech in adults at risk for severe COVID-19.

  Recruiting Phase 4 Henry M. Jackson Foundation for the Advancement of Military Medicine · Bethesda, Maryland · NCT07287137

• Observational study on COVID-19 effects during pregnancy

  This study looks at how COVID-19 infection during pregnancy affects both the mother and the baby's health to see if there are any differences compared to pregnant women who didn't have the virus.

  Recruiting at 5 sites Shandong University · Jinan, Shandong and 4 other locations · NCT06927622

• Omicron-based COVID-19 vaccine with Matrix-M given as a single dose in older adults and high-risk individuals

  A single-dose Omicron-subvariant vaccine with Matrix-M is tested to see if it is safe and can induce an immune response in adults 65+ and in younger adults with conditions that raise the risk of severe COVID-19, who were previously vaccinated.

  Recruiting at 20 sites Phase 4 Sanofi · Fair Oaks, California and 19 other locations · NCT07861542

• Secutrelvir for nonhospitalized COVID-19 in teens and adults

  This study tests whether secutrelvir can help nonhospitalized people with COVID-19 see faster symptom relief compared with a placebo.

  Recruiting Phase 3 Shionogi Inc. · Multiple Locations · NCT07746544

• Light-based immune boost to help prevent viral upper respiratory infections

  A daily handheld light therapy device is tested to see if it can lower how often adults at a military medical facility get colds, flu, or other upper respiratory infections.

  Recruiting Mike O'Callaghan Military Hospital · Nellis Air Force Base, Nevada · NCT07610967

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.